Ending Discrimination in COVID–19 Treatments Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Ending Discrimination in COVID-19 Treatments Act
This bill prohibits consideration of certain factors in decisions about access to federally provided treatments or vaccines for COVID-19.
As a condition of receiving the treatments or vaccines from the federal government, states, localities, and private entities must ensure that specified demographic characteristics (e.g., race, sex, and age) or other characteristics (e.g., vaccination status, veteran status, and political ideology or speech) are not taken into account when determining a patient's eligibility for treatments or vaccines.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 171: Ending Discrimination in COVID–19 Treatments Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-171/
"S. 171: Ending Discrimination in COVID–19 Treatments Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-171/.
S. 171, 118th Cong. (2026), https://openamerica.io/bill/118-S-171/.
[S. 171: Ending Discrimination in COVID–19 Treatments Act](https://openamerica.io/bill/118-S-171/)